A new UCLA imaging study reveals how inhaling 100 percent oxygen can harm the brain. The findings fly in the face of national guidelines for resuscitation and urge a new approach adding carbon dioxide to the gas mix to preserve brain function in patients.
Between 2000 and 2004, worldwide CO2 emissions increased at a rate that is over three times the rate during the 1990s?the rate increased from 1.1 % per year during the 1990s to 3.1% per year in the early 2000s.
Men with chronic gum disease may have an increased risk of tongue cancer, regardless of whether they smoke, according to a report in the May issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.
Celgosivir is a new class of antiviral medicine in clinical development for the treatment of chronic hepatitis C virus (HCV) infection. Researchers tested this new antiviral medicine and measured its potential to offer improved treatment outcomes when combined with other anti-HCV drugs.
A simple method of flash-heating breast milk infected with HIV successfully inactivated the free-floating virus, according to a new study led by researchers at the Berkeley and Davis campuses of the University of California.
Cervarix, the cervical cancer vaccine from GSK, has been granted a licence by the Therapeutic Goods Administration (TGA) of Australia for the prevention of cervical cancer and precancerous lesions associated with the most common cancer-causing human papillomavirus types.
Research shows that the prevalence of obesity is rising, causing an increase in heart disease and diabetes, among other conditions, but evidence has not yet been established linking obesity to precancerous lesions in the colon called polyps.
Childhood obesity is widely recognised as a major contributor towards cardiovascular diseases, diabetes, sleep disorders, and psychological and social problems.
Based on a Finnish study, persistent smokers may have higher risk to become depressed in comparison to never smokers. Also those smokers who quit have an elevated risk of depressive symptoms in short run. However, in long run this risk declines to the level of never smokers.
Data presented at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomist? (formoterol fumarate) Inhalation Solution, delivered by nebulization, is an effective and well-tolerated new treatment option for patients suffering from emphysema or chronic bronchitis, otherwise known as Chronic Obstructive Pulmonary Disease (COPD).